Sander Dale A., CFO and Chief Corporate Development Officer at Humacyte, Inc. ($HUMA), made one open market purchase of company shares in the last 365 days, totaling $30,600. His most recent buy occurred on April 10, 2025. This purchase ranks 3,409th among 4,983 insiders in our database, where the average buy amounts to about $1.5 million across 3.29 transactions. Sander Dale A. reported no open market sales during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 16, 2025 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A | Common Stock | 311100 | $0.00 | 353,700.0000 | 187,271,321 | 730.28% | 0.17% |
| April 10, 2025 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | P | Common Stock | 20000 | $1.53 | 42,600.0000 | 155,118,816 | 88.50% | 0.01% |
| Jan. 21, 2025 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A | Stock Options (right to buy) | 283101 | $0.00 | 283,101.0000 | 0 | 9999.99% | 0.00% |
| Dec. 19, 2024 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A | Stock Options (right to buy) | 525 | $0.00 | 2,625.0000 | 0 | 25.00% | 0.00% |
| Aug. 27, 2024 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | S | Common Stock | 39389 | $6.68 | 22,600.0000 | 0 | 63.54% | 0.00% |
| Aug. 27, 2024 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | M | Common Stock | 39389 | $2.56 | 61,989.0000 | 0 | 174.29% | 0.00% |
| Aug. 27, 2024 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | M | Stock Options (right to buy) | 39389 | $0.00 | 0.0000 | 0 | 100.00% | 0.00% |
| Dec. 8, 2023 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A | Stock Options (right to buy) | 301000 | $0.00 | 301,000.0000 | 0 | 9999.99% | 0.00% |
| Dec. 11, 2023 | Humacyte, Inc. | $HUMA | Sander Dale A. | CFO and Chief Corp. Deve. Off. | A | Stock Options (right to buy) | 525 | $0.00 | 2,100.0000 | 0 | 33.33% | 0.00% |